Literature DB >> 11221157

Neurological manifestations of children with systemic lupus erythematosus.

W F Loh1, I M Hussain, A Soffiah, Y N Lim.   

Abstract

In a cross-sectional study of 21 children with Systemic Lupus Erythematosus, 15 (71%) were found to have neuropsychiatric manifestations. The most common finding was generalised seizures (42.8%) followed by encephalopathy (19%) and hallucinations (19%). One child (4.76%) had hemichorea. In 3 children neurological manifestations were the first symptom of SLE. Computerised Axial Tomograms (CAT scans) showed cerebral atrophy in 7 of 12 scans available for review. Ten children had abnormal EEGs. Although none of the children had clinical evidence of a peripheral neuropathy, 8 had neurophysiological evidence of a neuropathy. One child died of intracranial haemorrhage. Six children had residual neuropsychiatric sequalae.

Entities:  

Mesh:

Year:  2000        PMID: 11221157

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  4 in total

1.  Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.

Authors:  Tricia S Williams; Cynthia Aranow; Gail S Ross; Alexandra Barsdorf; Lisa F Imundo; Andrew H Eichenfield; Philip J Kahn; Betty Diamond; Deborah M Levy
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

2.  Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus.

Authors:  Morel Ayala Zoilo; Benadón Eduardo; Faugier Enrique; Maldonado V M del Rocio
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

Review 3.  2013 update: Hopkins lupus cohort.

Authors:  Monthida Fangtham; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

Review 4.  Peripheral nerve disease secondary to systemic conditions in children.

Authors:  Jo M Wilmshurst; Robert A Ouvrier; Monique M Ryan
Journal:  Ther Adv Neurol Disord       Date:  2019-08-12       Impact factor: 6.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.